<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: We investigated the association between <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance status defined by a 75-g oral <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance test (OGTT) and the development of <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: A total of 1,017 community-dwelling <z:hpo ids='HP_0000726'>dementia</z:hpo>-free subjects aged ≥60 years who underwent the OGTT were followed up for 15 years </plain></SENT>
<SENT sid="2" pm="."><plain>Outcome measure was clinically diagnosed <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: The age- and sex-adjusted incidence of <z:hpo ids='HP_0000001'>all</z:hpo>-cause <z:hpo ids='HP_0000726'>dementia</z:hpo>, <z:hpo ids='HP_0002511'>Alzheimer disease</z:hpo> (AD), and vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (VaD) were significantly higher in subjects with <z:mp ids='MP_0002055'>diabetes</z:mp> than in those with <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance </plain></SENT>
<SENT sid="4" pm="."><plain>These associations remained robust even after adjustment for confounding factors for <z:hpo ids='HP_0000001'>all</z:hpo>-cause <z:hpo ids='HP_0000726'>dementia</z:hpo> and AD, but not for VaD (<z:hpo ids='HP_0000001'>all</z:hpo>-cause <z:hpo ids='HP_0000726'>dementia</z:hpo>: adjusted hazard ratio [HR] = 1.74, 95% confidence interval [CI] = 1.19 to 2.53, p = 0.004; AD: adjusted HR = 2.05, 95% CI = 1.18 to 3.57, p = 0.01; VaD: adjusted HR = 1.82, 95% CI = 0.89 to 3.71, p = 0.09) </plain></SENT>
<SENT sid="5" pm="."><plain>Moreover, the risks of developing <z:hpo ids='HP_0000001'>all</z:hpo>-cause <z:hpo ids='HP_0000726'>dementia</z:hpo>, AD, and VaD significantly increased with elevated 2-hour postload <z:chebi fb="105" ids="17234">glucose</z:chebi> (PG) levels even after adjustment for covariates, but no such associations were observed for fasting plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> (FPG) levels: compared with those with 2-hour PG levels of &lt;6.7 mmol/L, the multivariable-adjusted HRs of <z:hpo ids='HP_0000001'>all</z:hpo>-cause <z:hpo ids='HP_0000726'>dementia</z:hpo> and AD significantly increased in subjects with 2-hour PG levels of 7.8 to 11.0 mmol/L or over, and the risk of VaD was significantly higher in subjects with levels of ≥11.1 mmol/L </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS: Our findings suggest that <z:mp ids='MP_0002055'>diabetes</z:mp> is a significant risk factor for <z:hpo ids='HP_0000001'>all</z:hpo>-cause <z:hpo ids='HP_0000726'>dementia</z:hpo>, AD, and probably VaD </plain></SENT>
<SENT sid="7" pm="."><plain>Moreover, 2-hour PG levels, but not FPG levels, are closely associated with increased risk of <z:hpo ids='HP_0000001'>all</z:hpo>-cause <z:hpo ids='HP_0000726'>dementia</z:hpo>, AD, and VaD </plain></SENT>
</text></document>